Mode
Text Size
Log in / Sign up

Extended overnight fasting improves nighttime blood pressure dipping in overweight/obese adults

Extended overnight fasting improves nighttime blood pressure dipping in overweight/obese adults
Photo by Phillip Flores / Unsplash
Key Takeaway
Consider extended overnight fasting as a potential lifestyle intervention for cardiometabolic parameters, but evidence is preliminary.

A randomized parallel-arm controlled trial investigated extended overnight fasting in 39 overweight/obese participants aged 36-75 years. The intervention involved a 13-16-hour fasting window with the last meal consumed at least 3 hours before sleep, compared to a control condition of habitual fasting (11-13 hours). The primary outcome was nighttime dipping of diastolic blood pressure, which was significantly improved in the intervention group. The study followed participants for 7.5 weeks.

Regarding secondary outcomes, the intervention was associated with lower nighttime heart rate, higher heart rate variability, lower nighttime cortisol, lower glucose levels during an oral glucose tolerance test, and a higher 30-minute insulinogenic index. However, the Matsuda Index of insulin sensitivity did not show a significant improvement compared to the control group. Safety and tolerability data, including adverse events and discontinuations, were not reported in the provided evidence.

Key limitations of this evidence include the small sample size (39 participants), relatively short follow-up duration of 7.5 weeks, and the lack of reported safety and tolerability data. The practice relevance is framed as a novel and accessible lifestyle intervention with promising potential for improving cardiometabolic function. However, these findings should be interpreted cautiously as preliminary evidence from a small, short-term trial awaiting confirmation in larger, longer-duration studies with comprehensive safety monitoring.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up900.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Time-restricted eating has gained attention for its potential cardiometabolic health benefits. Existing time-restricted eating approaches may have limited adherence and sustainability due to fixed fasting windows with prolonged fasting duration before sleep, or they involve self-selected fasting windows without specifying the duration relative to sleep, a critical period for cardiometabolic regulation. We hypothesized that an individualized approach that extended overnight fasting duration by 3 hours in alignment with habitual sleep time (last meal ≥3 hours before sleep) would enhance nighttime autonomic balance, decrease blood pressure and heart rate, increase blood pressure per hour dipping, and glucose regulation compared with a control group maintaining habitual eating patterns. METHODS: In this randomized parallel-arm controlled trial, 39 overweight/obese participants (36-75 years) completed either an extended overnight fasting intervention (13-16-hour fasting) or a control condition (habitual fast of 11-13 hours). Both groups dimmed lights 3 hours before bedtime. The intervention duration was 7.5 weeks. RESULTS: Compared with control, extended overnight fasting intervention significantly improved the coprimary outcome of nighttime dipping of diastolic blood pressure, but not the Matsuda Index of insulin sensitivity. extended overnight fasting improved secondary measures of nighttime autonomic function and morning oral glucose tolerance, including lower nighttime heart rate, higher heart rate variability, lower nighttime cortisol, and during the Oral Glucose Tolerance Test, lower glucose level, and higher 30-minute insulinogenic index, indicating improved acute insulin response. CONCLUSIONS: Extending overnight fasting duration by 3 hours in alignment with sleep improved cardiometabolic health in middle-aged/older adults by strengthening coordination between circadian- and sleep-regulated autonomic and metabolic activity. This sleep-aligned time-restricted eating approach represents a novel, accessible lifestyle intervention with promising potential for improving cardiometabolic function.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.